Live from the NIH registry
Studies recruiting near Amarillo right now
Top 25 of 99 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Amarillo, TX Investigative Site 10045 — Amarillo, Texas (1.6 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: Akero Therapeutics, Inc
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - West Texas — Amarillo, Texas (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Amarillo Medical Specialists Rheumatology — Amarillo, Texas (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: 89bio, Inc.
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Amgen
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Southwest Retina Specialists — Amarillo, Texas (1.6 mi)
· Sponsor: EyeBiotech Ltd.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Texas Oncology - West Texas — Amarillo, Texas (1.6 mi)
· Sponsor: Pfizer
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
Communication
N/A
Interventional 14,400 participants sought
Northwest Texas Healthcare System — Amarillo, Texas (1.6 mi)
· Sponsor: Boston Children's Hospital
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: DalCor Pharmaceuticals
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: City of Hope Medical Center
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
Pharma Tex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: 89bio, Inc.
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
Phase 3
Interventional 3,527 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Acute Gout Flare, Gout Attack
Phase 2, Phase 3
Interventional 300 participants sought
Amarillo Center of Clinical Research — Amarillo, Texas (1.6 mi)
· Sponsor: Olatec Therapeutics, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Harrington Cancer Center ( Site 0061) — Amarillo, Texas (1.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)
Phase 2
Interventional 160 participants sought
Amarillo, Texas — Amarillo, Texas (1.6 mi)
· Sponsor: EyeBiotech Ltd.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: NRG Oncology
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Amarillo Medical Specialists LLP — Amarillo, Texas (1.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Breast Cancer
Phase 3
Interventional 420 participants sought
Texas Oncology West — Amarillo, Texas (1.6 mi)
· Sponsor: Hoffmann-La Roche
BOOM-IBD2 Pivotal Clinical Trial
Ulcerative Colitis, Inflammatory Bowel Diseases
N/A
Interventional 137 participants sought
Amarillo Premier Research (Objective Health) — Amarillo, Texas (1.6 mi)
· Sponsor: Boomerang Medical
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Phase 3
Interventional 150 participants sought
Lumos Pharma Investigational Site — Amarillo, Texas (1.6 mi)
· Sponsor: Lumos Pharma